Small-molecule inhibitors of p21 as novel therapeutics for chemotherapy-resistant kidney cancer

Author： Liu Ruiwu Wettersten Hiromi I Park See-Hyoung Weiss Robert H

ISSN： 1756-8927

Source： Future Medicinal Chemistry, Vol.5, Iss.9, 2013-06, pp. : 991-994

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Small-molecule inhibitors of human LDH5

By Granchi Carlotta Paterni Ilaria Rani Reshma Minutolo Filippo

Future Medicinal Chemistry, Vol. 5, Iss. 16, 2013-10 ,pp. : 1967-1991

Future Science

Access to resources Recommend Favorite

Recent progress in the discovery of small-molecule inhibitors of the HMT EZH2 for the treatment of cancer

By Verma Sharad K Knight Steven D

Future Medicinal Chemistry, Vol. 5, Iss. 14, 2013-09 ,pp. : 1661-1670

Future Science

Access to resources Recommend Favorite

PNAs as novel cancer therapeutics

By Luca Mologni

Letters in Peptide Science, Vol. 10, Iss. 3-4, 2003-01 ,pp. : 297-308

Springer Publishing Company

Access to resources Recommend Favorite

A three‐fluorophore FRET assay for high‐throughput screening of small‐molecule inhibitors of ribosome assembly

By Klostermeier Dagmar

Nucleic Acids Research, Vol. 32, Iss. 9, 2004-05 ,pp. : 2707-2715

Oxford University Press

Access to resources Recommend Favorite

Small molecule inhibitors of lysozyme amyloid aggregation

By Vieira Marcelo Figueroa-Villar J. Meirelles M. Ferreira Sérgio Felice Fernanda

Cell Biochemistry and Biophysics, Vol. 44, Iss. 3, 2006-10 ,pp. : 549-553

Humana Press, Inc

Access to resources Recommend Favorite